Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Back

ESC Premium Access

Inhaled iloprost, exercise hemodynamics, and ventricular performance in heart failure with preserved ejection fraction

Session: New treatment studies in heart failure

Topic: Pharmacotherapy

Speaker: Doctor J. Cheng (Taipei, TW)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Jen-Fang Cheng

National Taiwan University Hospital, Taipei (Taiwan)

0 follower

8 more presentations in this session

Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial

Speaker: Doctor D. Fouassier (Paris, FR)

Drug effect of luseogliflozin and voglibose on heart failure with preserved ejection fraction in diabetic patients: a multicenter randomized-controlled trial

Speaker: Doctor H. Kihara (Asahikawa, JP)

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)

Access

Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction

Speaker: Mr M. Godet (Rouen, FR)

Clinical predictors of NT-proBNP response to early initiation of sacubitril/valsartan after hospitalisation for decompensated heart failure: An analysis of the TRANSITION study

Speaker: Doctor D. Pascual Figal (Murcia, ES)

Access the full session

New treatment studies in heart failure

Speakers: Doctor J. Cheng, Doctor D. Fouassier, Doctor H. Kihara, Associate Professor A. Kalogeropoulos, Mr M. Godet...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources